Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation AHA 2024

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

Presenter: John Sapp

November 16, 2024

Presentation TCT 2024

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Presenter: Stephen Ellis

October 29, 2024

Presentation TCT 2024

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

Presenter: Ann Gage

October 29, 2024

Presentation TCT 2024

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

Presenter: CHANG HOON KIM

October 29, 2024

Presentation THT 2024

CMR in Ischemic Cardiomyopathy

Presenter: Jonathan Weinsaft

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation CTO 2024

Ischemic Cardiomyopathy: When and How Should I Revascularize?

Presenter: Jason Wollmuth

February 02, 2024

Advertisement

Catheter Ablation or Antiarrhythmic Drug Therapy for Ventricular Tachycardia in Ischemic Cardiomyopathy: The VANISH2 Trial

TCT 254: Importance of Change in LVEF with PCI on Risk of Cardiac Death or Hospitalization for Heart Failure in Pateients With Stable Ischemic Cardiomyopathy

TCT 255: Identifying Patients With Stable Ischemic Cardiomyopathy Whose LVEF Will Increase After PCI

Case Presentation: Cardiogenic Shock in a Patient With Non-ischemic Cardiomyopathy

TCT 792: Prognosis in Patients With Cardiogenic Shock According to Sex, With or Without Ischemic Cardiomyopathy

CMR in Ischemic Cardiomyopathy

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Ischemic Cardiomyopathy: When and How Should I Revascularize?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content